Thymus Cancer Companies

ID: MRFR/Pharma/1021-HCR

90 Pages

Satyendra Maurya

Last Updated: February 16, 2025

Thymus cancer, a rare malignancy affecting the thymus gland, has spurred innovative efforts from leading biotech companies. Pioneering the field is Oncogene Therapeutics, employing targeted therapies to inhibit cancer cell growth. Their groundbreaking approach aims to disrupt the disease's progression. Immunotech Solutions focuses on immunotherapies, harnessing the body's immune system to combat thymic tumors effectively.

Thymus Cancer Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)7.8%

2024 Market Size$ 0.49 Billion

2025 Market Size$ 0.52 Billion

2035 Market Size$ 1.11 Billion

Key Players

Bristol-Myers Squibb

Merck & Co.

AstraZeneca

Novartis

Roche

Pfizer

Trends

Rise of Targeted Therapies
Advancements in Diagnostic Tools
Increased Research Funding

Opportunities

Regulatory Support and Approvals
Increased Awareness and Education
Growing Incidence of Thymus Cancer

Summary Table of Contents Segmentation Methodology Download PDF

Customize Report

Certified Researchers

Top Industry Leaders in the Thymus Cancer Market

Latest Thymus Cancer Companies Update

Novartis drug Afinitor (everolimus) received FDA approval in combination with chemotherapy for advanced unresectable thymic carcinoma, offering a new treatment option for patients.

Amgen drug Blincyto (blinatumomab) is being investigated in a Phase 2 clinical trial for relapsed or refractory thymic carcinoma, potentially expanding its therapeutic applications.

AstraZeneca PARP inhibitor Lynparza (olaparib) is being explored in clinical trials for thymic epithelial tumors with BRCA mutations, offering personalized treatment options.

MeDiPharm A Korean biopharmaceutical company received Phase 3 trial approval in the US for their novel drug MDN-111 for thymic carcinoma, raising hopes for potential market entry.

List of Thymus Cancer Key Companies in the Market

Amgen Inc. (US)
Astellas Pharma Inc. (Japan)
Eli Lilly and Company (US)
Merck & Co. Inc. (the US)
Novartis AG (Switzerland)
Celgene Corporation (US)
Pfizer Inc. (US)
Mylan NV (US)
Johnson & Johnson Services Inc. (the US)
Onxeo (France)
Bristol-Myers Squibb Company (US)
Boston Biomedical Inc. (the UK)
AstraZeneca (UK)
Takeda Pharmaceutical Company Limited (Japan)
Tiziana Life Sciences plc (UK)
Teva Pharmaceutical Industries Ltd (Israel)

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”